MSN/FOX19: Johnson & Johnson COVID-19 vaccine still very effective, UC professor says
UC expert says the important thing is getting as many people vaccinated as possible
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was interviewed for a story on the COVID-19 vaccine from by Johnson & Johnson which showed an effective rate of 66%. WXIX-TV/FOX19 produced the story locally which was picked up by MSN nationally.
Fichtenbaum says it's still worthwhile for people to get the J & J vaccine despite that comparitively low effectiveness rate
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
With Moderna testing at 94% effective and Pfizer testing at 95%, Fichtenbaum expects that people will have a preference in which vaccine they will receive.
“When we continue to test new vaccines, we’re testing them in a different environment where there are these strains that are emerging where the vaccine may not respond as well,” Fichtenbaum says. “So, if we tested Moderna or Pfizer vaccine under those conditions, would they still be the same as 95%? I’m not so certain.”
Lead photo/Getty Images
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Local 12: Head injury survivor, doctor share importance of...
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
WVXU: Why is part of Green Township called Dent?
April 23, 2024
UC College of Arts and Sciences professor tells WVXU that Ohio's glacial past might explain how Dent got its name.
WVXU: Find your CPAP annoying? UC researchers are working on a...
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.